The Psychedelics Newsletter, Issue 139

PSYCH Symposium: shifting perceptions, in conversation with Robin Carhart-Harris??

At PSYCH Symposium in the British Museum on 6 July, a conversation between Professor Robin Carhart-Harris and journalist Kate Spicer explored the impact of psychedelic research on culture and the future of psychedelics in society.

PSYCH Symposium’s day of discussions was closed with an intimate conversation between Robin Carhart-Harris, Professor of Neurology & Psychiatry, Director Psychedelics Division, University of California, San Francisco (UCSF) and journalist Kate Spicer.

Carhart-Harris, formerly of Imperial College London, discussed his recent opportunity in becoming the Ralph Metzner Distinguished Professor in Neurology and Psychiatry at UCSF, highlighting the progressive approach in the US that will be “leading the way in the future” with psychedelic research.

READ MORE

PSYCH Symposium: London 2023 took place at the British Museum on 6 July, to provide a stage for the industry’s most influential figures to connect, collaborate, and expedite the adoption of psychedelic healthcare.

WATCH THE WRAP-UP VIDEO

THE IMPACT OF SSRIS ON PSILOCYBIN THERAPY

It was previously thought the medication could interfere with the therapeutic potential of the psychedelic medicine.?

READ MORE

PSYCHEDELIC SOLUTIONS FOR POLICE AND SOCIETY

PSYCH Symposium explored the mental health crisis facing police forces across the UK.?

READ MORE

BUSINESS AND INVESTMENT

• Numinus Wellness?reports financial results. ?The company recorded a quarterly gross profit of C$2.1 million.
• Paper calls for clarity on definition of?psychedelic-assisted psychotherapy. ?Researchers examine definitions as they relate to psilocybin treatment.
• First CPT code for?psychedelic therapies released. ?An application was lodged by COMPASS Pathways and MAPS PBC.
• Algernon?announces private placement. ?It hopes to raise C$205,000 to fund drug development.
• BetterLife?closes private placement. ?The company issued 2,200,000 units to raise C$220,000.

SCIENCE AND RESEARCH

• DMT research receives?US$1.5 million donation. ?The donation will help launch a research programme at UC San Diego.
• Microdosing LSD?linked to improved sleep. ?Those who microdosed slept an extra 24 minutes the following night.
• Sixty-one per cent of US voters support regulated?access to psychedelic medicines. ?The survey was conducted by UC Berkeley Center for the Science of Psychedelics.

?REGULATIONS AND LEGISLATION

• California's psilocybin legalisation campaign?approved for 2024 ballot. ?Decriminalize California can now collect signatures in support of its initiative.
• Former US official calls for?widespread drug decriminalisation. ?LaBelle was chief of staff at the Office of National Drug Control Policy.

ARTICLES OF INTEREST

• People with mental health issues three times more likely to be?behind on bills. ?Sixty per cent said they felt unable to cope due to the rising cost of living.
• Fifth of women having a mental health crisis asked if?they were menstruating. ?Calls for help were sometimes unseen, unheard or dismissed.